Legislative record

HB 1198STATE · TennesseeIntroduced

Drugs, Prescription - As enacted, adds mandating the use of biosimilar drugs as a cost-saving measure the bureau of TennCare may implement; adds that a health carrier, health benefit plan, or utilization review organization may require a patient to try a biosimilar product prior to providing coverage for the equivalent branded prescription drug; requires the TennCare pharmacy advisory committee to consider as a factor the use of biosimilar drugs in the committee's recommendation to the bureau of TennCare on any drugs to be added to the state preferred drug list. - Amends TCA Title 4; Title 53; Title 56; Title 68 and Title 71.

Latest action: Pub. Ch. 206

Voted 4/28/2025

Roll-call record

How representatives voted

0 yea·0 nay

No roll-call votes recorded for this bill yet.

Docket history

Action history

  1. 4/28/2025Pub. Ch. 206
  2. 4/28/2025Effective date(s) 04/11/2025
  3. 4/11/2025Signed by Governor.
  4. 4/3/2025Signed by Senate Speaker
  5. 4/3/2025Transmitted to Governor for his action.
  6. 4/2/2025Enrolled; ready for sig. of H. Speaker.
  7. 4/2/2025Signed by H. Speaker
  8. 3/31/2025H. adopted am. (Amendment 1 - HA0140)
  9. 3/31/2025Sponsor(s) Added.
  10. 3/31/2025Passed H., as am., Ayes 92, Nays 1, PNV 0